Showing results (181-190 of 760) with videos related to

Sort By:
Pageof 76
Expert Review of Anticancer Therapy|July 1, 2008
Bortezomib in the front-line treatment of multiple myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.
Blood|July 28, 2012
How I treat plasma cell leukemiaNiels W C J van de Donk, Henk M Lokhorst, Kenneth C Anderson, et al.
Cancers|June 11, 2020
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2011
In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cellsDharminder Chauhan, Ze Tian, Bin Zhou, et al.
Seminars in Oncology|October 19, 2013
Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targetsPanisinee Lawasut, Richard W J Groen, Eugen Dhimolea, et al.
Expert Opinion on Pharmacotherapy|November 28, 2017
Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and againstPaul G Richardson, Sarah A Holstein, Robert L Schlossman, et al.
Leukemia|April 3, 2020
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathwaysTeru Hideshima, Daisuke Ogiya, Jiye Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2005
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myelomaTeru Hideshima, James E Bradner, Jason Wong, et al.
Pageof 76